Situs ambiguus
|
0.500 |
Biomarker
|
disease |
CTD_human |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Heterotaxy Syndrome
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Heterotaxy Syndrome
|
0.500 |
Biomarker
|
disease |
CTD_human |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Situs ambiguus
|
0.500 |
SusceptibilityMutation
|
disease |
ORPHANET |
|
|
|
Multiple congenital anomalies
|
0.300 |
Biomarker
|
group |
CTD_human |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Asplenia Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Polysplenia Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Right Atrial Isomerism
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Left Atrial Isomerism
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development.
|
10053005 |
1999 |
Situs ambiguous
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
|
|
|
Ciliopathies
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Ciliopathies
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Left‑right determination factor 2 (LEFTY2), a suppressor of cell proliferation and tumor growth, is a negative regulator of EC progression.
|
29845221 |
2018 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
These findings show that the TGFB4 (ebaf) mRNA has distinct tumor specific expression.
|
9230066 |
1997 |
Malignant neoplasm of endometrium
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Using western blot analysis and immunofluorescence assays, it was demonstrated that overexpression of miR‑215 markedly downregulated LEFTY2 protein expression levels in HEC‑1A cells and LEFTY2 protein expression was downregulated in EC tissues, which was inversely correlated with miR‑215 expression.
|
29845221 |
2018 |
Endometrial Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Using western blot analysis and immunofluorescence assays, it was demonstrated that overexpression of miR‑215 markedly downregulated LEFTY2 protein expression levels in HEC‑1A cells and LEFTY2 protein expression was downregulated in EC tissues, which was inversely correlated with miR‑215 expression.
|
29845221 |
2018 |
Coronary heart disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Statistical analyses showed that the rs2295418 (g.C925A) variant in Lefty2 gene was obviously associated with the risk of CHD (P value = 0.016<0.05).
|
25111179 |
2014 |
Ventricular Septal Defects
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In this report, we show that the average expression of EBAF in the disease tissues of VSD patients was lower than the expression in normal fetuses without VSD.
|
23899608 |
2013 |
Proteus Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
This overview of asymmetry addresses the following topics: chiral molecules; asymmetric signaling molecules, including N-cadherin, Shh, Fgf8, lefty1, lefty2, nodal, Pitx2, activin betaB, activin receptor IIA, and cSnR; situs abnormalities; asymmetric cell division; laterality in humans and animals; behavioral asymmetry in humans and animals; asymmetric embryopathies, including Tessier-type "clefts"; hemiasymmetries such as hemihyperplasia, hemihypoplasia, and hemiatrophy; asymmetric vascular syndromes, including Klippel-Trenaunay and Sturge-Weber syndromes; plagiocephaly of the synostotic and deformational types; somatic mosaicism, including a discussion of McCune-Albright syndrome, fibrous dysplasia, GNAS1 mutations, and Proteus syndrome.
|
11471152 |
2001 |
Endometriosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
During the critical period of endometrial receptivity, ebaf protein was more abundant in patients with endometriosis who did not conceive than in patients who became pregnant.
|
10902804 |
2000 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
However, some serous adenocarcinomas of the ovary also exhibited TGFB4 (ebaf) mRNA.
|
9230066 |
1997 |
Embryonal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The testicular tumors, seminomas and embryonal carcinomas, also expressed TGFB4 (ebaf) mRNA.
|
9230066 |
1997 |